---
title: How Does Medical Clown Intervention Affect the Length of Hospitalization in Children With Pneumonia
nct_id: NCT06750029
overall_status: COMPLETED
phase: NA
sponsor: Carmel Medical Center
study_type: INTERVENTIONAL
primary_condition: Community-Acquired Pneumonia (CAP)
countries: Israel
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT06750029.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT06750029"
ct_last_update_post_date: 2024-12-27
last_seen_at: "2026-05-12T06:24:32.385Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# How Does Medical Clown Intervention Affect the Length of Hospitalization in Children With Pneumonia

**NCT ID:** [NCT06750029](https://clinicaltrials.gov/study/NCT06750029)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 51
- **Lead Sponsor:** Carmel Medical Center
- **Conditions:** Community-Acquired Pneumonia (CAP)
- **Start Date:** 2018-10-30
- **Completion Date:** 2023-11-07
- **CT.gov Last Update:** 2024-12-27

## Brief Summary

Background and Objectives: Community-acquired pneumonia (CAP) is a leading cause of hospitalization in children. The hospitalization duration depends on factors as child's well-being, vital signs, need for parenteral treatments, and development of complications. Medical clowns (MCs) are known to assist in reducing pain and alleviating anxiety and have been integrated into many aspects of hospital treatment routines. The aim of this study is to evaluate the effect of MC intervention on length of hospitalization in children admitted with CAP.

## Eligibility

- **Minimum age:** 2 Years
- **Maximum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* Clinical diagnosis of pneumonia.
* Ages 2-18 years.

Exclusion Criteria:

* Hemodynamically unstable patients.
* Other systemic comorbidities or chronic respiratory diseases
* Children from families unable to comprehend and sign an informed consent form.
```

## Arms

- **Investigation Group** (EXPERIMENTAL) — Investigation group will be receiving standard care plus 15-minute MC visits twice daily during the first 48 hours of hospitalization
- **Control Group** (NO_INTERVENTION) — Control Group will be receiving standard care without MC visits.

## Interventions

- **Medical clown visits** (OTHER) — The intervention is 15-minute visits from MCs twice daily during the first two days of admission. The clowns use various techniques to relax the patients (e.g. music, singing, playing, humor, guided imagination) and helpe encourage children to begin drinking and eating on their own.

## Primary Outcomes

- **The length of hospitalization in hours** _(time frame: Immediately after the intervention)_ — The length of hospitalization in hours is determined by the duration between admission and discharge from the pediatric department.

## Secondary Outcomes

- **Duration of IV treatment** _(time frame: Immediately after the intervention)_

## Locations (1)

- Carmel Medical Center, Haifa, Israel

## Recent Field Changes (last 30 days)

- `eligibility.sex` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `outcomes.secondary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.carmel medical center|haifa||israel` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT06750029.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT06750029*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*